IDS Launch Allergy

IDS are pleased to announce the launch of the Allergy panel on the IDS-iSYS Multi-Discipline Automated System. Omega Diagnostics, our partner, are developing a range of allergens and have appointed IDS as an exclusive, global distributor. At launch, the initial menu includes 60 CE Marked assays for Specific IgE and Total IgE. The 60 allergens […]

Join IDS at Medlab Asia Pacific 2019

If you work in the medical laboratory sector, then Medlab Asia Pacific is an event not to miss. The meeting offers a unique insight into future trends and innovations within the industry, and a networking opportunity with over 250 companies, showcasing solutions from a range of laboratory diagnostics, instruments, equipment, and more, from more than […]

CEO Discusses Value Created by IDS

“We are a specialist in-vitro diagnostic solution provider to the clinical laboratory market,” begins Jaap Stuut, the Group CEO of Immunodiagnostic Systems (IDS). His firm and proud statement is equally substantiated by the value that the company has created over the years. IDS has not only manufactured more than 1000 systems. Last year IDS launched […]

Join IDS at MEDICA 2018 from 12th until 15th of November

MEDICA is the largest medical trade fair in the world. It hosts over 5,100 exhibitors, from 70 different countries, showcasing their in-patient and out-patient medicine, medical technology, diagnostic systems and electromedical and laboratory equipment. As usual, the exhibition will be held in the Messe Düsseldorf Arena. The event welcomes industry leaders from the fields of […]

Meet IDS at MEDLAB Europe 2018 from the 2nd until the 4th of October

MEDLAB Europe is the only medical laboratory multidisciplinary exhibition and congress in the region. It provides a platform for scientific learning and business networking. MEDLAB offers an unmissable opportunity with over 2,000 laboratory and trade professionals, from over 130 countries, in attendance. In 2018, over 150 industry exhibitors will be present, showcasing the most innovative […]